Biopharma Business

Tag "France"

French Biotech Could Be Taking its Diabetes Drug to Phase III on its own

Poxel was able to score positive results for its type 2 diabetes drug in a Phase IIb study in Japan, preparing the company to go for a Phase III program. Poxel, one of

Read Full Article

Novasep Opens New Bioconjugation Unit in France

  On Feb. 23, 2017, Novasep announced the opening of its new €11-million (approximately $11.64 million) bioconjugation unit in the company’s Le Mans site in France. The 2000m facility includes two

Read Full Article

SGS expand elemental analysis and testing capabilities

Biopharmaceutical, analytical and bioanalytical contract solutions provider, SGS has announced that it is expanding its elemental analysis and testing capabilities at its Villeneuve-la-Garenne, France laboratory. The site has invested in

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here